Annual report pursuant to Section 13 and 15(d)

Supplemental Financial Information

v3.10.0.1
Supplemental Financial Information
12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Supplemental Financial Information
18.
Supplemental Financial Information

Quarterly Results of Operations (Unaudited)
 
The following table presents the unaudited statements of operations data for each of the eight quarters in the period ended December 31, 2018. The information has been presented on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.

Unaudited Quarterly Results of Operations 
(in thousands, except share and per share amounts) 
 
 
Three months ended
 
 
 
 
March 31,
2018
 
June 30,
2018
 
September 30,
2018
 
December 31,
2018
 
Total for year
2018
 
 
 
 
 
 
 
 
 
 
 
Revenue - sales
 
$
1,726

 
$
483

 
$
1,169

 
$
1,071

 
$
4,449

 
 
 
 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
Cost of product sales
 
5,436

 
4,600

 
6,453

 
6,272

 
22,761

Research and development cost
 
1,475

 
1,203

 
967

 
857

 
4,502

General and administrative expense
 
1,775

 
3,913

 
2,174

 
6,352

 
14,214

Total operating expenses
 
8,686


9,716


9,594


13,481


41,477

Loss from operations
 
(6,960
)

(9,233
)

(8,425
)

(12,410
)

(37,028
)
Other income and expense
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(587
)
 
(719
)
 
(919
)
 
(1,222
)
 
(3,447
)
Interest and other income
 
17

 
25

 
81

 
100

 
223

Total other expense, net
 
(570
)

(694
)

(838
)

(1,122
)

(3,224
)
 
 
 
 
 
 
 
 
 
 
 
Loss before income tax expense
 
(7,530
)
 
(9,927
)
 
(9,263
)
 
(13,532
)
 
(40,252
)
Income tax expense
 
(2
)
 

 

 

 
(2
)
Net loss
 
(7,532
)

(9,927
)

(9,263
)

(13,532
)

(40,254
)
Weighted average shares outstanding, basic and diluted
 
27,768,008

 
30,134,995

 
38,779,710

 
38,905,282

 
34,154,826

Basic and diluted net loss per share
 
$
(0.27
)

$
(0.33
)

$
(0.24
)

$
(0.35
)

$
(1.18
)
 
 
 
Three months ended
 
 
 
 
March 31,
2017
 
June 30,
2017
 
September 30,
2017
 
December 31,
2017
 
Total for year
2017
 
 
 
 
 
 
 
 
 
 
 
Revenue - sales
 

 
603

 
589

 
896

 
2,088

 
 
 
 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
Cost of product sales
 

 
2,531

 
3,140

 
3,870

 
9,541

Research and development cost
 
2,987

 
2,184

 
1,367

 
1,565

 
8,103

General and administrative expense
 
1,528

 
1,444

 
1,925

 
1,994

 
6,891

Impairment charge
 
 
 
2,411

 

 

 
2,411

Total operating expenses
 
4,515


8,570


6,432


7,429


26,946

Loss from operations
 
(4,515
)
 
(7,967
)
 
(5,843
)
 
(6,533
)
 
(24,858
)
Other income and expense
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(388
)
 
(408
)
 
(454
)
 
(511
)
 
(1,761
)
Interest and other income
 
11

 
10

 
7

 
13

 
41

Total other expense, net
 
(377
)

(398
)

(447
)

(498
)

(1,720
)
 
 
 
 
 
 
 
 
 
 
 
Loss before income tax expense
 
(4,892
)
 
(8,365
)
 
(6,290
)
 
(7,031
)
 
(26,578
)
Income tax expense
 
(2
)
 

 

 

 
(2
)
Net loss
 
(4,894
)

(8,365
)

(6,290
)

(7,031
)

(26,580
)
Weighted average shares outstanding, basic and diluted
 
18,792,850

 
20,123,041

 
20,265,020

 
21,956,993

 
20,293,100

Basic and diluted net loss per share
 
(0.26
)

(0.42
)

(0.31
)

(0.32
)

(1.31
)